03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Erbitux 100mg/50ml* : | |
Type | Medicine Non Marketed |
Originator | Biotech (Erbitux 100mg/50ml) |
Agent | Food & Drug Corporation |
Distributor | Food & Drug Corporation |
Laboratory | Merck |
Responsible Party | Merck KGaA |
Origin | Germany |
Manufacturer | Merck KGaA |
Origin | Germany |
ATC | L01XC06 |
Erbitux 100mg/50ml* :
Erbitux 100mg/50ml* :
Erbitux 100mg/50ml* :
Erbitux 100mg/50ml* :
Erbitux 100mg/50ml* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
ALT increased | Very Common |
AST increased | Very Common |
Blepharitis | Uncommon |
Blood alkaline phosphatase increased | Very Common |
Cellulitis | Not known |
Congestive heart failure | Not known |
Conjunctivitis | Common |
Decreased appetite | Common |
Deep vein thrombosis | Uncommon |
Dehydration | Common |
Dermatitis acneiform | Not known |
Diarrhoea (Diarrhea) | Common |
Dry skin | Not known |
Dysphagia | Not known |
Epistaxis (Nasal bleeding) | Not known |
Erysipelas | Not known |
Fatigue | Common |
Febrile neutropenia (Neutropenic fever) | Not known |
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) | Not known |
Headache | Common |
Hepatic enzyme increased | Very Common |
Hypertrichosis | Not known |
Hypocalcaemia | Common |
Hypomagnesaemia | Very Common |
Infusion related reaction | Very Common |
Interstitial pneumonitis | Uncommon |
Keratitis | Uncommon |
Leucopenia (Leukopenia) | Not known |
Lyell Syndrome (Toxic epidermal necrolysis) | Very rare |
Lymphopenia | Not known |
Meningitis aseptic | Not known |
Mucosal inflammation | Very Common |
Myocardial infarction | Not known |
Myocardial ischaemia | Not known |
Nail disorders | Not known |
Nausea | Common |
Necrotizing fasciitis | Not known |
Neutropenia | Not known |
Paronychia | Not known |
Pneumonia | Not known |
Pruritus | Not known |
Pulmonary embolism | Uncommon |
Radiation skin injury | Not known |
Sepsis (Systemic infection) (Sepsis state) | Not known |
Skin exfoliation (Flaking skin) | Not known |
Skin necrosis | Not known |
Skin reaction | Very Common |
Staphylococcal scalded skin syndrome | Not known |
Stevens-Johnson syndrome | Very rare |
Superinfection | Not known |
Vomiting | Common |
Weight decreased (Weight loss) | Not known |
Erbitux 100mg/50ml* :
NB : Products With Same Indication |
Different Units By MoH Code
Erbitux 100mg/50ml* MoH 3908 :
Form | Solution for infusion |
Packaging | Bottle |
Package Size | 50ml |
Strength | 100mg/50ml |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 194337/05 |
Submission date | 01/01/2005 |
Registration Year | 2005 |
Archived Date | 2014 |
Price Comparison
● Country: | Kuweit | |
● Package Size: | 1 | |
● Public Price: | 112.24 KWD | ( 32,951,531.44 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 112,24 KWD | ( 32,881,072.00 LBP ) |
● Pharmacy Price: | 94.82 KWD | ( 27837350.42 LBP ) |
● Pricing Date: | 07/02/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 50ml Vial | |
● Public Price: | 1349.5 AED | ( 32,605,269.50 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1349,5 AED | ( 32,593,189.00 LBP ) |
● Pharmacy Price: | 1149.62 AED | ( 27775968.82 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 1x50ml | |
● Public Price: | 1349.5 AED | ( 32,605,269.50 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1349,5 AED | ( 32,593,189.00 LBP ) |
● Pharmacy Price: | 1149.62 AED | ( 27775968.82 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File